ACI Archean Chemical Industries Q4 FY25 results (Jan–Mar 2025) and concall
Archean Chemical reported a resilient Q4 FY25 with total revenue of INR 333.33 crores and an EBITDA margin of 30.3%, despite global headwinds. The company saw strong recovery in Industrial Salt volumes and progress in Bromine Derivatives, targeting over 50% utilization. For the full FY25, revenue was INR 1,063.45 crores with a 35% EBITDA margin. Strategic initiatives in semiconductor manufacturing and energy storage are progressing, and a final dividend of INR 3 per share was recommended.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 238 | 243 | 322 |
| EBITDA | 76 | 84 | 90 |
| Net profit | 22 | 56 | 58 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
